Microsoft, DNA analysis startup to develop algorithm to predict heart disease

Microsoft Healthcare is teaming up with Spiral Genetics, a DNA analysis startup, to identify correlations between the human genome and heart disease characteristics, GeekWire reports.

Advertisement

Three notes:

1. Spiral Genetics will apply machine learning technology to develop an algorithm that can analyze and identify genetic markers of heart disease.

2. Microsoft Healthcare will contribute access to its cloud enterprise Microsoft Azure, collaboration with its Microsoft Genomics team as well as financial support.

3. The partnership is part of Spiral Genetics’ re-launch after leaving its parent company Fabric. Spiral Genetics was founded in 2009 and was acquired by biotechnology company Omica, which rebranded to Fabric in 2017.

More articles on artificial intelligence:
Robot-assisted surgery leaves new surgeons without crucial skills, study finds
AI advances in the workforce may affect more women than men, report says
AI demistifyed with new Lenovo AI workstation

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.